Nootropic activity of lipid-based extract of Bacopa monniera Linn. compared with traditional preparation and extracts

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 11, 2009, Pages 1537-1544

  Lohidasan, Sathiyanarayanan ^a   Paradkar, Anant R ^b   Mahadik, Kakasaheb R ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Bacopa monniera Linn.; Gelucire; Ghrita; Memory; Nootropic activity

Indexed keywords

ACYLGLYCEROL; AYURVEDIC DRUG; BACOPA MONNIERI EXTRACT; BRAIN MONOAMINE; DOPAMINE; GELUCIRE; LIPID; MACROGOL; METHANOL; NOOTROPIC AGENT; NORADRENALIN; SCOPOLAMINE; SEROTONIN; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTEROGRADE AMNESIA; ARTICLE; AVOIDANCE BEHAVIOR; BIOLOGY; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DRUG MEGADOSE; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HYDROPHILICITY; INTERMETHOD COMPARISON; MALE; MAZE TEST; NONHUMAN; NORADRENALIN BRAIN LEVEL; RAT; RECOGNITION; SCREENING; SEROTONIN BLOOD LEVEL; STRESS;

AMNESIA, ANTEROGRADE; ANIMALS; AVOIDANCE LEARNING; BACOPA; BRAIN; CHOLINERGIC ANTAGONISTS; CHROMATOGRAPHY, THIN LAYER; DOPAMINE; DOSAGE FORMS; LIPIDS; MALE; MAZE LEARNING; NOOTROPIC AGENTS; NOREPINEPHRINE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SAPONINS; SCOPOLAMINE; SEROTONIN; TRITERPENES;

EID: 75749084486     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp/61.11.0014     Document Type: Article

References (44)

1. Dhingra D et al. Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol 2004; 91: 361-365.
2. Singh HK, Dhawan BN. Effect of Bacopa monniera Linn (Brahmi) extract on avoidance responses in rat. J Ethnopharmacol 1982; 5: 205-214.
3. Malhotra CL, Das PK. Pharmacological studies on Herpestis monneri. Indian J Med Res 1959; 47: 244-305.
4. Aithal HN, Sirsi M. Pharmacological investigation of Herpestis monneri. Indian J Pharm 1961; 23: 2-5.
5. Shabana C et al. Anti-inflammatory activity of Bacopa monniera in rodents. J Ethnopharmacol 2006; 104: 286-289.
6. Singh HK, Dhawan BN. Neuropsychopharmacological effects of Ayurvedic nootropic Bacopa monneri Linn. (Bramhi). Indian J Pharmacol 1997; 29: 359-365.
7. Chopra RN et al. Glossary of Indian Medicinal Plants. New Delhi: Council of scientific and Industrial Research, 1956.
8. Tripathi YB et al. Bacopa monneri Linn. as an antioxidant: Mechanism of action. Indian J Exp Biol 1996; 34: 523-526.
9. Goel RK et al. In vitro evaluation of Bacopa monniera on anti-Helicobacter pylori activity and accumulation of prostaglandins. Phytomedicine 2003; 10: 523-527.
10. Hota SK et al. Bacopa monniera leaf extract ameliorates hypobaric hypoxia induced spatial memory impairment. Neurobiol Dis 2009; 34: 23-39.
11. Saraf MK et al. Bacopa monniera ameliorates amnesic effects of diazepam qualifying behavioral-molecular partitioning. Neuroscience 2008; 155: 476-484.
12. Prakash JC, Sirsi M. Comparative study of effect of Bramhi (Bacopa monniera) and chlorpromazine on motor learning in rats. J Sci Ind Res (C) 1962; 21: 93-96.
13. Kishore K, Singh M. Effect of bacosides, alcoholic extract of Bacopa monniera Linn. (Brahmi), on experimental amnesia in mice. Indian J Exp Biol 2005; 43: 640-645.
14. Chatterjee N et al. Chemical examination of Bacopa monniera Wettst: Part I - Isolation of chemical constituents. Indian J Chem 1963; 1: 212-215.
15. Chatterjee N et al. Chemical examination of Bacopa monniera Wettst: Part II - The constitution of Bacoside A. Indian J Chem 1965; 3: 24-29.
16. Basu N et al. Chemical examination of Bacopa monniera,Wettst: Part III - Bacoside B. Indian J Chem 1967; 5: 84-86.
17. Singh HK et al. Effect of bacosides A and B on avoidance responses in rats. Phytother Res 1988; 2: 70-75.
18. Kulkuni RD. Principles of Pharmacology in Ayurved. Mumbai, India: Ram Sangam Graphics, 1997.
19. Singh RB et al. Association of trans fatty acids (vegetable ghee) and clarified butter (Indian ghee) intake with higher risk of coronary artery disease in rural and urban populations with low fat consumption. Int J Cardiol 1996; 56: 299-300.
20. Lip GY et al. Dietary fat purchasing habits in whites, blacks and Asian peoples in England - implications for heart disease prevention. Int J Cardiol 1995; 48: 287-293.
21. Jacobson MS. Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations. Lancet 1987; 2: 656-658.
22. Chauhan B et al. Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique. AAPS Pharm Sci Tech 2005; 6: E405-412.
23. Abdul-Fattah AM, Baraga HN. Preparation and in vitro evaluation of solid dispersions of halofantrine. Int J Pharm 2002; 235: 17-33.
24. Aïnaoui A, Vergnaud JM. Modelling the plasma drug level with oral controlled release forms with lipidic Gelucire. Int J Pharm 1998; 169: 155-162.
25. Sheu MT, Hsia AHO. Polyglycolized saturated glycerides as carrier and enhancer for drug penetration. Chin Pharm J 2001; 53: 107-111.
26. Kristina SB et al. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of Rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells. J Pharm Pharm Sci 2007; 10: 319-331.
27. Chambin O, Jannin V. Interest of multifunctional lipid excipients: case of Gelucire 44/14. Drug Dev Ind Pharm 2005; 31: 527-534.
28. Gupta AP et al. Effect of drying on the bacoside A content of the harvested Bacopa monniera shoots revealed using a new high performance thin layer chromatography. J Med Aromat Plan Sci 1998; 20: 1052-1055.
29. Organisation for Economic Co-operation and Development. Guidance Document on Acute Oral Toxicity Testing Series on Testing And Assessment No 24. Paris: OECD Environment, health and safety publications, 2001; www.oecd.org/ehs (accessed 12 May 2008).
30. Conrad CD et al. Sex differences in spatial and non-spatial Y-maze performance after chronic stress. Neurobiol Learn Mem 2003; 79: 32-40.
31. Akwa Y et al. The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms? Proc Natl Acad Sci USA 2001; 98: 14033-14037.
32. Cook L, Weidley E. Behavioral effects of some psychopharmacological agents. Ann NY Acad Sci 1957; 66: 740-752.
33. Lakshmana MK, Raju TR. An isocratic assay for norepinephrine, dopamine, and 5-hydroxytryptamine using their native fluorescence by high-performance liquid chromatography with fluorescence detection in discrete brain areas of rat. Anal Biochem 1997; 246: 166-170.
34. Wang JH et al. Improved spatial recognition memory in mice lacking adenosine A2A receptors. Exp Neurol 2006; 199: 438-445.
35. Craig DQM. The use of glycerides as controlled release matrices. In: Karsa DR, Stephenson RA, eds. Excipients and Delivery Systems for Pharmaceutical Formulations. London: Royal Society of Chemistry, 1995: 148-173.
36. Fukushima K et al. Pharmaceutical approach to HIV protease inhibitor atazanavir for bioavailability enhancement based on solid dispersion system. Biol Pharm Bull 2007; 30: 733-738.
37. Rege BD et al. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci 2002; 16: 237-246.
38. Luker GD et al. Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol. J Biol Chem 1999; 274: 6979-6991.
39. Haritova AM et al. Functional studies on the activity of efflux transporters in an ex vivo model with chicken splenocytes and evaluation of selected fluoroquinolones in this model. Biochem Pharmacol 2007; 73: 752-759.
40. Ahuja N et al. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm 2007; 65: 26-38.
41. Chen MC et al. Elevating bioavailability of cyclosporine A via encapsulation in artificial oil bodies stabilized by caleosin. Biotechnol Prog 2005; 21: 1297-1301.
42. Sheikh N et al. Effect of Bacopa monniera on stress induced changes in plasma corticosterone and brain monoamines in rats. J Ethnopharmacol 2007; 11: 671-676.
43. Essman WB. Serotonin in health and disease. In: Essman WB, ed. The Central Nervous System. Serotonin in Learning & Memory, Volume III. New York: Spectrum, 1978: 70-71.
44. David AM et al. Role of brain norephinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 1214-1224.